Sofinnova Investments, Inc. Sarepta Therapeutics, Inc. Transaction History

Sofinnova Investments, Inc.

$1.06 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$113.33 - $163.85 $3.59 Million - $5.18 Million	-31,636 Reduced 13.91%	195,852 $30.9 Million
Q1 2024 Aug 14, 2024	BUY	$93.7 - $141.53 $2.96 Million - $4.48 Million	31,636 Added 16.15%	227,488 $29.5 Million
Q1 2024 May 15, 2024	BUY	$93.7 - $141.53 $21.3 Million - $32.2 Million	227,488 New	227,488 $29.5 Million
Q1 2023 May 11, 2023	SELL	$117.53 - $155.99 $15.1 Million - $20.1 Million	-128,890 Reduced 51.98%	119,065 $16.4 Million
Q4 2022 Feb 13, 2023	BUY	$100.86 - $132.13 $10.7 Million - $14.1 Million	106,515 Added 75.31%	247,955 $32.1 Million
Q3 2022 Nov 08, 2022	BUY	$75.71 - $119.24 $771,863 - $1.22 Million	10,195 Added 7.77%	141,440 $15.6 Million
Q2 2022 Aug 15, 2022	BUY	$62.69 - $88.44 $2.66 Million - $3.75 Million	42,365 Added 47.67%	131,245 $9.84 Million
Q1 2022 May 16, 2022	SELL	$63.15 - $90.42 $2.01 Million - $2.88 Million	-31,852 Reduced 26.38%	88,880 $6.94 Million
Q4 2021 Feb 14, 2022	SELL	$77.28 - $99.42 $2.82 Million - $3.63 Million	-36,547 Reduced 23.24%	120,732 $10.9 Million
Q3 2021 Nov 15, 2021	SELL	$65.97 - $92.48 $9.32 Million - $13.1 Million	-141,221 Reduced 47.31%	157,279 $14.5 Million
Q2 2021 Aug 16, 2021	BUY	$69.38 - $86.75 $20.7 Million - $25.9 Million	298,500 New	298,500 $23.2 Million
Q1 2021 May 14, 2021	SELL	$72.25 - $168.95 $3.75 Million - $8.76 Million	-51,848 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$125.56 - $178.74 $6.51 Million - $9.27 Million	51,848 New	51,848 $8.84 Million
Q2 2020 Aug 13, 2020	SELL	$93.0 - $171.7 $9.45 Million - $17.4 Million	-101,603 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$82.38 - $131.64 $1.14 Million - $1.81 Million	13,785 Added 15.7%	101,603 $9.94 Million
Q4 2019 Feb 14, 2020	SELL	$76.53 - $135.58 $1.42 Million - $2.52 Million	-18,596 Reduced 17.48%	87,818 $11.3 Million
Q3 2019 Nov 14, 2019	BUY	$72.81 - $156.91 $7.75 Million - $16.7 Million	106,414 New	106,414 $8.02 Million
Q1 2019 May 15, 2019	SELL	$106.67 - $151.68 $5.22 Million - $7.42 Million	-48,894 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$97.32 - $148.76 $1.85 Million - $2.82 Million	18,979 Added 63.44%	48,894 $5.34 Million
Q3 2018 Nov 15, 2018	SELL	$115.31 - $161.51 $2.13 Million - $2.99 Million	-18,485 Reduced 38.19%	29,915 $4.83 Million
Q2 2018 Nov 15, 2018	BUY	$71.74 - $153.69 $3.11 Million - $6.67 Million	43,414 Added 870.72%	48,400 $6.4 Million
Q2 2018 Aug 14, 2018	BUY	$71.74 - $153.69 $357,695 - $766,298	4,986 New	4,986 $659,000

Others Institutions Holding SRPT

# of Institutions

529

Shares Held

84.2M

Call Options Held

2.06M

Put Options Held

1.52M

Black Rock Inc. New York, NY

10.3M
Shares

$1.23 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

8.97M
Shares

$1.07 Billion
0.02% of portfolio
Capital International Investors Los Angeles, CA

6.26M
Shares

$745 Million
0.16% of portfolio
Janus Henderson Group PLC London, X0

4.36M
Shares

$519 Million
0.29% of portfolio
State Street Corp Boston, MA

4.27M
Shares

$508 Million
0.02% of portfolio

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.4B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sofinnova Investments, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sofinnova Investments, Inc. with notifications on news.

Account